A Summary of BioPhorum data used in A Systemic Approach for the Evaluation, Validation, and Implementation of Automated Colony Counting Systems
A PDA Journal of Pharmaceutical Science and Technology publication
In March 2022 the BioPhorum Operations Group (BPOG) published an article in the PDA Journal of Pharmaceutical Science and Technology; A Systematic Approach for the Evaluation, Validation, and Implementation of Automated Colony Counting Systems. This article covers robust data provided by several industry experts from leading pharmaceutical manufacturing companies, providing a firsthand view into the benefits of implementing automation for routine quality control microbiology testing: specifically focusing on automated sample handling, incubation, and enumeration.
This short, on-demand webinar (less than 15 minutes) offers a summary of the article providing the highlights and key impacts when implementing automation into a quality control manufacturing environment.
Join Vid Malhotra as he takes a deep dive into the comparison of the automated technologies compared in the article; autofluorescence systems (such as our Growth Direct® (GD)) to HD camera and illumination only systems.
Key takeaways will cover:
- Benefits and values of the GD over the competition
- Components of automation technology
- Impacts on QC microbiology and data integrity
- Enhancements of rapid throughput and sample capacity
Additional related resources mentioned in this presentation are accessible below:
Link to BPOG Paper Abstract
RMB Commitment & Resources
Pharma. 4.0, LIMS Integration, and System Validation
Impact of USP Ch <1117>
4-Part Series on Strengthening a Weak Link in Microbial Testing (Part 1, Part 2, Part 3, Part 4)
McKinsey on Evolution of Quality Control
To access this free, 14-minute webinar on demand, please take a moment to complete the form.
Vidur Malhotra, Strategy Manager Rapid Micro Biosystems
Prior to joining Rapid Micro Biosystems, Vidur was a Senior Associate at EY-Parthenon, a management consulting firm. While in consulting, Vidur worked on 30+ strategy and due diligence projects primarily in the Life Sciences and Manufacturing verticals. He holds a degree in biomedical engineering from Duke University.
At Rapid Micro Biosystems, Vidur has managed several projects including voice of customer research, consumables sales data analysis, market intelligence monitoring, and new product release strategies.